Mycobacterium tuberculosis and SARS‐CoV‐2 Co‐Infection: An Efficient Cell Model to Study Lung Host–Pathogen Interactions
Current Protocols · 2026
DOI: 10.1002/cpz1.70433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2026. Verfasst von Thays Maria Costa de Lucena und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Center of Biosciences, Laboratory of Human Genetics and Molecular Biology, Federal University of Pernambuco, Recife, Brazil. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Coinfection, Host-Pathogen Interactions, SARS-CoV-2. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo a Ciência e Tecnologia de Pernambuco (FACEPE), Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
In less than a year, SARS‐CoV‐2 managed to displace Mycobacterium tuberculosis (Mtb) as the leading cause of death worldwide due to a single infectious agent. Both pathogens affect the respiratory tract, mainly the lungs. However, the impact that a possible Mtb + SARS‐CoV‐2 co‐infection can have on the host response is still unknown. Herein we depict a rigorous system to evaluate the complex interaction between two simultaneous infections in vitro in a lung epithelial cell line (A549). Overall, the process includes eight steps: (1) Mtb culture, (2) cell maintenance, (3) preparation of viral stocks, (4) determination of infectious titers, (5) Mtb and SARS‐CoV‐2 co‐infection, (6) determination of intracellular bacterial load, (7) SARS‐CoV‐2 viability test, and (8) optional UV‐C validation assay for infectivity reduction. This comprehensive protocol will allow experimentalists to study the pathogenesis of co‐infection in vitro and facilitate collaborative work in the literature. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol : In vitro coinfection model using Mtb and SARS‐CoV‐2 in human lung epithelial cells
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Center of Biosciences, Laboratory of Human Genetics and Molecular Biology, Federal University of Pernambuco, Recife, Brazil.
- Molecular Biology Sector, Keizo Asami Institute, Federal University of Pernambuco, Recife, Brazil.
- Laboratory of Virology and Experimental Therapy, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil.
- Laboratory of Immunoparasitology, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife, Brazil.
ORCID-Profile: Thays Maria Costa de Lucena
Förderung
- Fundação de Amparo a Ciência e Tecnologia de Pernambuco (FACEPE)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
de Lucena, T. M. C., Miranda, D. E. O., Arcoverde, J. V. B., Cavalcanti, M. S. B., Dantas, W. M., Pena, L. J., Rabello, M. C. D. S., & de Azevêdo Silva, J. (2026). Mycobacterium tuberculosis and SARS‐CoV‐2 Co‐Infection: An Efficient Cell Model to Study Lung Host–Pathogen Interactions. Current Protocols. https://doi.org/10.1002/cpz1.70433
Vancouver
de Lucena TMC, Miranda DEO, Arcoverde JVB, Cavalcanti MSB, Dantas WM, Pena LJ, et al. Mycobacterium tuberculosis and SARS‐CoV‐2 Co‐Infection: An Efficient Cell Model to Study Lung Host–Pathogen Interactions. Current Protocols. 2026. doi:10.1002/cpz1.70433
BibTeX
@article{deLucena2026,
author = {de Lucena, Thays Maria Costa and Miranda, Débora Elienai de Oliveira and Arcoverde, Juliana Vieira de Barros and Cavalcanti, Mariana Souza Bezerra and Dantas, Willyene Marilia and Pena, Lindomar José and Rabello, Michelle Christiane da Silva and de Azevêdo Silva, Jaqueline},
title = {Mycobacterium tuberculosis and SARS‐CoV‐2 Co‐Infection: An Efficient Cell Model to Study Lung Host–Pathogen Interactions},
journal = {Current Protocols},
year = {2026},
doi = {10.1002/cpz1.70433}
}
EUVIMED